These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11359364)

  • 1. Anergy and human immunodeficiency virus infection.
    Hegde HR; Robbins SM
    Med Hypotheses; 2001 Mar; 56(3):376-80. PubMed ID: 11359364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anergy and acquired immune deficiency syndrome.
    Hegde HR; Woodman RC; Robbins SM
    Med Hypotheses; 2001 Feb; 56(2):250-5. PubMed ID: 11425298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutrients as modulators of anergy in acquired immune deficiency syndrome.
    Hegde HR; Woodman RC; Sankaran K
    J Assoc Physicians India; 1999 Mar; 47(3):318-25. PubMed ID: 10999129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anergy and chemokine receptors.
    Hegde HR
    J Assoc Physicians India; 2002 Jun; 50():816-8. PubMed ID: 12240851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impairment of the immune system by HIV infection].
    Arndt R; Keeser D
    Z Hautkr; 1989 May; 64(5):353-4, 357-8, 363. PubMed ID: 2525849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV pathogenesis: gp120-antibody complexes bind CD4 and kill T4 cells--immunotoxin therapy should prevent the progression of HIV to AIDS.
    Chaplin JW
    Med Hypotheses; 1999 Feb; 52(2):133-46. PubMed ID: 10340294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive cellular immune impairment leading to development of AIDS: two-year prospective study of HIV infection in drug addicts.
    Fernandez-Cruz E; Fernandez AM; Gutierrez C; Garcia-Montes M; de la Morena MT; Rodriguez-Villanueva J; Longo N; Zabay JM
    Clin Exp Immunol; 1988 May; 72(2):190-5. PubMed ID: 3261660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmunity, anergy, lentiviral immunity and disease.
    Ansari AA
    Autoimmun Rev; 2004 Nov; 3(7-8):530-40. PubMed ID: 15546802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients.
    Bassani S; López M; Toro C; Jiménez V; Sempere JM; Soriano V; Benito JM
    Clin Infect Dis; 2007 Jan; 44(1):105-10. PubMed ID: 17143825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
    Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
    Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients.
    Jaye A; Sarge-Njie R; Schim van der Loeff M; Todd J; Alabi A; Sabally S; Corrah T; Whittle H
    J Infect Dis; 2004 Feb; 189(3):498-505. PubMed ID: 14745708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological aspects of HIV infection.
    Macchi B; Petruzzelli MA; De Laurenzi V
    Clin Ter; 1992 Feb; 140(2):169-77. PubMed ID: 1568358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of preserving HIV-specific immune responses.
    Kaufmann DE; Rosenberg ES
    J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development.
    Betts MR; Gray CM; Cox JH; Ferrari G
    Expert Rev Vaccines; 2006 Aug; 5(4):505-16. PubMed ID: 16989631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunopathogenesis and therapeutic approaches in acquired immunologic deficiency syndrome (AIDS)].
    Zielinski C
    Acta Med Austriaca; 1987; 14(1):5-9. PubMed ID: 2956821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biology of human immunodeficiency virus infection].
    de Martino M; Resti M; Muccioli AT; Galli L; Azzari C; Vierucci A
    Pediatr Med Chir; 1987; 9(4):381-9. PubMed ID: 3320988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of CC chemokine receptor 5 and CD4 expression and human immunodeficiency virus type 1 replication in human macrophages and microglia by T helper type 2 cytokines.
    Wang J; Crawford K; Yuan M; Wang H; Gorry PR; Gabuzda D
    J Infect Dis; 2002 Apr; 185(7):885-97. PubMed ID: 11920312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemokine receptors: their role in human immunodeficiency virus (HIV) pathogenicity and resistance to HIV infections].
    Us D
    Mikrobiyol Bul; 2003 Jan; 37(1):75-87. PubMed ID: 12838682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
    Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
    Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.